Reply

Anders Boyd¹, Gilles Peytavin², Karine Lacombe^{3

4}

Affiliations

¹ INSERM UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
² Bichat-Claude Bernard Hospital, Pharmaco-Toxicology Department, AP-HP and INSERM, UMR 1137 IAME, Paris, France.
³ Department of Infectious and Tropical Diseases, Saint-Antoine Hospital, AP-HP, Paris, France.
⁴ Sorbonne Universités, UPMC University Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

Comment

Anders Boyd et al. Hepatology. 2016 Sep.

. 2016 Sep;64(3):1000-1.

doi: 10.1002/hep.28463. Epub 2016 Mar 7.

Anders Boyd¹, Gilles Peytavin², Karine Lacombe^{3

4}

¹ INSERM UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
² Bichat-Claude Bernard Hospital, Pharmaco-Toxicology Department, AP-HP and INSERM, UMR 1137 IAME, Paris, France.
³ Department of Infectious and Tropical Diseases, Saint-Antoine Hospital, AP-HP, Paris, France.
⁴ Sorbonne Universités, UPMC University Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

No abstract available

Comment on

Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.
Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K. Boyd A, et al. Hepatology. 2014 Aug;60(2):497-507. doi: 10.1002/hep.27182. Epub 2014 Jun 20. Hepatology. 2014. PMID: 24752996 Clinical Trial.
Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression.
Wong TC, Lan A, Kiser JJ, Anderson PL, Patel K, Tillman H, Naggie S. Wong TC, et al. Hepatology. 2016 Sep;64(3):999-1000. doi: 10.1002/hep.28461. Epub 2016 Mar 18. Hepatology. 2016. PMID: 26799354 Free PMC article. No abstract available.